In a post-hoc analysis, elderly patients with type 2 diabetes experienced less hypoglycemia and similar blood sugar reductions with JANUVIA compared to sulfonylurea
In a post-hoc analysis, elderly patients with type 2 diabetes treated with JANUVIA achieved similar blood sugar reductions as those treated with a sulfonylurea. Notably, patients taking JANUVIA experienced significantly less hypoglycemia, with an incidence of 6.2% compared to 28.2% in patients taking a sulfonylurea.